Related Experiment Video
Updated: Jun 8, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
METTL3 accelerates staphylococcal protein A (SpA)-induced osteomyelitis progression by regulating m6A
Ding Gao1, Jian Shi2, Siyu Lu2
1Department of Orthopedic Trauma Surgery, Meizhou People's Hospital, Meizhou, 514031, China.
Abstract:
Osteomyelitis (OM) is an inflammatory disease of bone infection and destruction characterized by dysregulation of bone homeostasis. Staphylococcus aureus (SA) has been reported to be the most common pathogen causing infectious OM. Recent studies have demonstrated that N6-methyladenosine (m6A) regulators are associated with the development of OM. However, the molecular mechanism of m6A modifications in OM remains unclear. Here, we investigated the function of methyltransferase-like 3 (METTL3)-mediated m6A modification in OM development. In this study, human bone mesenchymal stem cells (hBMSCs) were treated with staphylococcal protein A (SpA), a vital virulence factor of SA, to construct cell models of OM. Firstly, we found that METTL3 was upregulated in OM patients and SpA-induced hBMSCs, and SpA treatment suppressed osteogenic differentiation and induced oxidative stress and inflammatory injury in hBMSCs. Functional experiments showed that METTL3 knockdown alleviated the inhibition of osteogenic differentiation and the promotion of oxidative stress and inflammation in SpA-treated hBMSCs. Furthermore, METTL3-mediated m6A modification upregulated miR-320a expression by promoting pri-miR-320a maturation, and the mitigating effects of METTL3 knockdown on SpA-mediated osteogenic differentiation, oxidative stress and inflammatory responses can be reversed by miR-320 mimic. In addition, we demonstrated that phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) was a downstream target of miR-320a, upregulation of PIK3CA alleviated miR-320a-induced inhibition of osteogenic differentiation, and upregulation of oxidative stress and inflammatory responses during SpA infection. Finally, we found that silencing METTL3 alleviated OM development by regulating the miR-320a/PIK3CA axis. Taken together, our data demonstrated that the METTL3/m6A/miR-320a/PIK3CA axis regulated SpA-mediated osteogenic differentiation, oxidative stress, and inflammatory responses in OM, which may provide a new therapeutic strategy for OM patients.
Insights
Methyltransferase-like 3 (METTL3) regulates bone homeostasis in osteomyelitis (OM) by controlling the m6A/miR-320a/PIK3CA axis. Silencing METTL3 alleviates OM development by mitigating inflammation and oxidative stress.
Area of Science:
- Molecular Biology
- Biochemistry
- Immunology
Background:
- Osteomyelitis (OM) is a bone infection disrupting homeostasis, often caused by Staphylococcus aureus (SA).
- N6-methyladenosine (m6A) regulators are implicated in OM, but their precise role is unclear.
- Methyltransferase-like 3 (METTL3) is a key m6A regulator investigated in this study.
Purpose of the Study:
- To investigate the function of METTL3-mediated m6A modification in osteomyelitis development.
- To elucidate the molecular mechanism involving METTL3, miR-320a, and PIK3CA in SA-induced bone damage.
Main Methods:
- Human bone mesenchymal stem cells (hBMSCs) were treated with staphylococcal protein A (SpA) to model OM.
- METTL3 expression, osteogenic differentiation, oxidative stress, and inflammatory responses were analyzed.
- Functional assays involved METTL3 knockdown, miR-320a mimic, and PIK3CA manipulation.
Main Results:
- METTL3 was upregulated in OM patients and SpA-treated hBMSCs, exacerbating osteogenic inhibition, oxidative stress, and inflammation.
- METTL3 knockdown ameliorated SpA-induced damage, while miR-320a mimic reversed these protective effects.
- The miR-320a/PIK3CA axis was identified as a key downstream pathway regulated by METTL3.
Conclusions:
- The METTL3/m6A/miR-320a/PIK3CA axis plays a critical role in regulating osteogenic differentiation, oxidative stress, and inflammation in OM.
- Targeting the METTL3/m6A pathway offers a potential therapeutic strategy for osteomyelitis.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway
Translational Regulation

